À retenir
Among 4030 US adults, each 1-unit rise in the triglyceride-glucose (TyG) index was associated with higher odds of sarcopenia (OR 1.31, 95% CI 1.07-1.60) after full adjustment. This is a cross-sectional snapshot, so it cannot show that insulin resistance causes muscle loss.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sarcopenia is the loss of muscle mass and strength, and whether insulin resistance contributes to it is debated. The authors tested whether the TyG index, a blood-test marker of insulin resistance built from triglycerides and glucose, is linked to sarcopenia and whether the link changes at certain levels or in certain groups.
Population et méthode
Cross-sectional study of 4030 participants aged 20 and older from the US National Health and Nutrition Examination Survey (NHANES) 2011-2018. A weighted logistic regression estimated the association between the TyG index and sarcopenia, with threshold effect analysis and restricted cubic splines to describe a nonlinear link, plus interaction tests and subgroup analyses.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1In the fully adjusted model, each 1-unit increase in the TyG index was associated with higher odds of sarcopenia (OR 1.31, 95% CI 1.07-1.60).
- 2The association was stronger in people without metabolic syndrome (MetS) or diabetes, and in those without vigorous or moderate work activity.
- 3The relationship was nonlinear, with a turning point at a TyG index of 9.14.
Limites et incertitude
- 1Cross-sectional data cannot tell whether high TyG came before sarcopenia or follows it.
- 2The abstract does not say how sarcopenia was defined, nor give the number of cases or the effect on either side of the 9.14 turning point.
- 3Subgroup results, such as those without MetS or diabetes, may be less reliable than the main finding and are not formally confirmed.
- 4This reading is based on the abstract only.
Mise en perspective
A raised TyG index may be one more signal that metabolic health and muscle health are linked, but one cross-sectional study cannot show that improving insulin resistance will protect muscle. Questions about blood triglycerides, glucose or muscle weakness belong with your clinician.
Vos données
The TyG index needs a fasting triglyceride and glucose test, so a wearable cannot calculate it. If you have lab results, you can track them over time, along with daily steps and strength training sessions, and compare results from the same lab and fasting conditions.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
The Triglyceride-glucose (TyG) index is a marker of insulin resistance, but its role in sarcopenia is controversial. The purpose of this study was to investigate the association of the TyG index with sarcopenia.
Methods
4030 participants aged 20 years and above were selected from National Health and Nutrition Examination Survey for cross sectional study. Weighted logistic regression model was used to estimate the association between TyG index and sarcopenia. Threshold effect analysis and restricted cubic spline were employed to describe nonlinear link, with interaction tests and subgroup analyses performed.
Results
It was found in the fully adjusted model that the TyG index was positively associated with sarcopenia (per 1-unit increase in the TyG index: OR = 1.31, 95%CI: 1.07, 1.60). This association was further highlighted in groups characterized by the absence of MetS or diabetes, as well as the absence of vigorous or moderate work activity. Furthermore, analysis of the curve fitting and threshold effects indicated a nonlinear relationship, which exhibited a turning point at 9.14.
Conclusion
The study results indicated that the TyG index was positively associated with sarcopenia. Enhancing the management of insulin resistance could help reduce the risk of developing sarcopenia.
Sources et attribution
The association between the triglyceride-glucose index and sarcopenia: data from the NHANES 2011-2018.
Yang J, Liu C, Zhao S, Wang L, Wu G, Zhao Z, Li C.
Lipids in health and disease · 2024-07-19
DOI: 10.1186/s12944-024-02201-1 ↗PubMed · 39030624 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

